Redefining the Role of Cardiovascular Imaging in Patients with Pulmonary Arterial Hypertension

被引:0
作者
Benjamin H. Freed
Amit R. Patel
Roberto M. Lang
机构
[1] University of Chicago Medical Center,Section of Cardiology, Department of Medicine
[2] University of Chicago MC 5084,undefined
来源
Current Cardiology Reports | 2012年 / 14卷
关键词
Right ventricle; Pulmonary arterial hypertension; Cardiovascular imaging; Two-dimensional echocardiography; Real-time three-dimensional echocardiography; Cardiovascular magnetic resonance; Prognostic parameters; Clinical end points;
D O I
暂无
中图分类号
学科分类号
摘要
While pulmonary arterial hypertension is a disease primarily affecting the pulmonary vasculature, the right ventricle plays an integral part in the disease process. Although widely used, two-dimensional echocardiography is limited in visualizing the right ventricle and, therefore, assessment of its structure and function has been largely subjective or invasive. Advanced imaging modalities such as real-time three-dimensional echocardiography and cardiovascular magnetic resonance overcome many challenges of two-dimensional echocardiography and have provided further insight into the pathophysiology of pulmonary arterial hypertension. Indices of right ventricular function obtained from these noninvasive techniques are being assessed for their prognostic capabilities as well as their ability to monitor response to pulmonary arterial hypertension–specific therapies. Future research is needed to compare the accuracy, reproducibility, and prognostic value of each of these parameters to definitively establish the role of cardiovascular imaging in the management of patients with pulmonary arterial hypertension.
引用
收藏
页码:366 / 373
页数:7
相关论文
共 130 条
[1]  
Badesch DB(2009)Diagnosis and assessment of pulmonary arterial hypertension J Am Coll Cardiol 54 S55-S66
[2]  
Champion HC(2009)Updated clinical classification of pulmonary hypertension J Am Coll Cardiol 54 S43-54
[3]  
Sanchez MAG(2005)The right ventricle in pulmonary hypertension Coron Arery Dis 16 13-18
[4]  
Simonneau G(2004)Treatment of pulmonary arterial hypertension N Engl J Med 351 1425-1436
[5]  
Robbins IM(1991)Survival in patients with primary pulmonary hypertension. Results from a national prospective registry Ann Intern Med 115 343-349
[6]  
Beghetti M(2009)End points and clinical trial design in pulmonary arterial hypertension J Am Coll Cardiol 54 S97-S107
[7]  
Chin KM(2010)Predicting survival in pulmonary arterial hypertension: Insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management (REVEAL) Circulation 122 164-172
[8]  
Kim NH(1999)Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension. PPH Study Group. Primary pulmonary hypertension Am J Cardiol 84 481-484
[9]  
Rubin LJ(2007)Endpoints in trials of new therapies for pulmonary arterial hypertension Eur Respir Dis 2 41-44
[10]  
Humbert M(2011)Current therapeutics and practical management strategies for pulmonary arterial hypertension Am Heart J 162 201-213